HomeInsightsStock Comparison

Solara Active Pharma Sciences Ltd vs Vivanza Biosciences Ltd Stock Comparison

Solara Active Pharma Sciences Ltd vs Vivanza Biosciences Ltd Stock Comparison

Last Updated on: Jun 24, 2025

Key Highlights

  • The Latest Trading Price of Solara Active Pharma Sciences Ltd is ₹ 540.9 as of 24 Jun 11:24.
  • The P/E Ratio of Solara Active Pharma Sciences Ltd changed from 10.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Vivanza Biosciences Ltd changed from 687.4 on March 2021 to 48.5 on March 2024 . This represents a CAGR of -48.46% over 4 years.
  • The Market Cap of Solara Active Pharma Sciences Ltd changed from ₹ 1190 crore on March 2020 to ₹ 1340 crore on March 2024 . This represents a CAGR of 2.41% over 5 yearsThe Market Cap of Vivanza Biosciences Ltd changed from ₹ 52.24 crore on March 2021 to ₹ 27.16 crore on March 2024 . This represents a CAGR of -15.09% over 4 years.
  • The revenue of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 278.96 crore as compare to the Dec '24 revenue of ₹ 301.8 crore. This represent the decline of -7.57% The revenue of Vivanza Biosciences Ltd for the Mar '25 is ₹ 0.53 crore as compare to the Dec '24 revenue of ₹ 1.51 crore. This represent the decline of -64.9%.
  • The ebitda of Solara Active Pharma Sciences Ltd for the Mar '25 is ₹ 51.32 crore as compare to the Dec '24 ebitda of ₹ 59.17 crore. This represent the decline of -13.27% The ebitda of Vivanza Biosciences Ltd for the Mar '25 is ₹ -0.91 crore as compare to the Dec '24 ebitda of ₹ 0.13 crore. This represent the decline of -800%.
  • The net profit of Solara Active Pharma Sciences Ltd changed from ₹ -19.11 crore to ₹ -2.1 crore over 8 quarters. This represents a CAGR of -66.85% The net profit of Vivanza Biosciences Ltd changed from ₹ 0.49 crore to ₹ -1 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Solara Active Pharma Sciences Ltd changed from 4.77 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Vivanza Biosciences Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Solara Active Pharma Sciences Ltd

  • Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs).
  • The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru. The Company offer rich basket of niche high-value products for global markets.
  • The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others.
  • It also reinforce entry barriers to competition and build strong intrinsic value through market specific launches.

About Vivanza Biosciences Ltd

  • Vivanza Biosciences Ltd (Previously known Ivee Injectaa Limited) was established in March, 1982 as a Private Limited Company and was converted into a Public Limited Company in May, 1992.
  • Head quartered in Gujarat, India, the Company came into existence in April 2016 with the sole aim to further spread its wings in global market with global quality pharmaceutical products at competitive pricing system. The Company is presently engaged in the business of Pharmaceutical Products and Pharma Products. However Competition in the industry is continuously increasing.
  • New technology is being adopted and steps are taken to improve the manufacturing capacity of the Company.
  • Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units. The company undertook an expansion-cum-diversification programme to increase its capacity from 18 lac pa to 54 lac pa.

Solara Active Pharma Sciences Ltd News Hub

News

Solara Active Pharma's Ambernath facility clears USFDA inspection

The Agency with their designated investigator inspected the facility from 5th to 9th May 2...

Read more

12 May 2025 08:36

News

Solara Active Pharma Sciences to conduct board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

07 May 2025 17:24

News

Solara Active Pharma Sciences to convene board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

27 Mar 2025 10:23

News

Solara Active Pharma Sciences to hold board meeting

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

22 Mar 2025 10:11

News

Solara Active Pharma Sciences to incorporate wholly owned subsidiary

Solara Active Pharma Sciences approved the incorporation of wholly owned subsidiary in rel...

Read more

07 Feb 2025 11:00

News

Solara Active Pharma Sciences announces board meeting date

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company...

Read more

16 Jan 2025 16:10

Vivanza Biosciences Ltd News Hub

News

Vivanza Biosciences to table results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

08 May 2025 11:19

News

Vivanza Biosciences announces board meeting date

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 12 May...

Read more

07 May 2025 11:35

News

Vivanza Biosciences to discuss results

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 31 Jan...

Read more

25 Jan 2025 10:18

News

Vivanza Biosciences to declare Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 17 Oct...

Read more

11 Oct 2024 10:17

News

Vivanza Biosciences to announce Quarterly Result

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 8 Augu...

Read more

03 Aug 2024 17:02

News

Vivanza Biosciences to convene AGM

Vivanza Biosciences announced that the 42nd Annual General Meeting (AGM) of the company wi...

Read more

08 Jul 2024 10:49

SWOT Analysis Of Vivanza Biosciences Ltd

Strength

2

S

Weakness

3

W

Opportunity

1

O

Threats

0

T

SWOT Analysis Of Solara Active Pharma Sciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Vivanza Biosciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Solara Active Pharma Sciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd

Which company has a larger market capitalization, Solara Active Pharma Sciences Ltd or Vivanza Biosciences Ltd?

Market cap of Solara Active Pharma Sciences Ltd is 2,388 Cr while Market cap of Vivanza Biosciences Ltd is 8 Cr

What are the key factors driving the stock performance of Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd?

The stock performance of Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd?

As of June 24, 2025, the Solara Active Pharma Sciences Ltd stock price is INR ₹534.35. On the other hand, Vivanza Biosciences Ltd stock price is INR ₹2.18.

How do dividend payouts of Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd compare?

To compare the dividend payouts of Solara Active Pharma Sciences Ltd and Vivanza Biosciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions